PharmaDeals Reports
PharmaDeals® publishes a series of highly respected reports tailored to the pharmaceutical and biotechnology sector. Each one serves as an effective and insightful partnering information resource.
Analysis of Deals in Neurodegenerative Diseases
This essential report will help you to identify key trends and who your prospective partners are within the area of neurodegenerative diseases.
This new report follows the highly acclaimed and popular report series on key deal making therapy areas. It focuses on the five major neurodegenerative diseases:
- Alzheimer’s disease
- Parkinson’s disease
- Multiple sclerosis
- Epilepsy
- Migraine
The report contains analysis of deals by deal and product type, number of deals year on year and the value and stage of development of these deals. It looks at the key players and includes case studies of the key deals being made within the five neurodegenerative diseases.
All deal data in this report are taken from the world-leading PharmaDeals® v4 Agreements database.
Also available in Electronic version (ISBN 978-0-9562710-6-8). Please contact us for a tailored quote for your organisation on +44 (0)1865 332723
All deal data in this report are taken from the world-leading PharmaDeals® v4 Agreements database.
Also available in Electronic version (ISBN 978-0-9562710-6-8). Please contact us for a tailored quote for your organisation on +44 (0)1865 332723
Contact us today
enquiries@pharmadeals.net
enquiries@pharmadeals.net
